Skip to content

Total at other companies

Bowhead Specialty Holdings logo
Bowhead Specialty HoldingsBOW
$81.19M-31.2%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$71.53M-5.4%
Geron logo
GeronGERN
$270.37M-27.2%
Eagle Bancorp logo
Eagle BancorpEGBN
$1.01B-24.2%
GitLab logo
GitLabGTLB
$619.16M-1.8%
Eastern Bankshares, Inc. logo
Eastern Bankshares, Inc.EBC
$96.34M+68.6%

Other financials

Income statement

See full
Revenue$1.8M+24.4%
Operating income-$37.9M-104%
Net income$26.5M+121%
EPS (diluted)$0.10+105%

Balance sheet

See full
Cash & equivalents$66.4M+247%
Total debt$58.4M+1,068%
Total equity-$245.9M+34.7%
Total assets$130.8M-76.5%

Cash flow

See full
Operating cash flow-$29.5M-78.7%
CapEx$5.5M+138%
Free cash flow-$35.0M-86.0%

Valuation

See full
Market cap$1.05B-18.6%
Enterprise value$1.04B
P/S252.8×

Profitability

See full
Operating margin-2,695.8%
Net margin-10,366.9%
FCF margin-278%

Returns & leverage

See full
Return on equity-21.5%
Debt / equity-0.2×
Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: KDK’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KDK's total?
KDK (KDK) reported total of $25.24M in Q1 2026.